Literature DB >> 1068529

Prognostic factors in acute leukemia.

E A Gehan, T L Smith, E J Freireich, G Bodey, V Rodriquez, J Speer, K McCredie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1068529

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  9 in total

1.  Immunological characteristics of lymphoblasts and lymphocytes in acute lymphoblastic leukaemia in children.

Authors:  D Olive; D Sabolovic; M C Beugnot; M Beaugnon
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

2.  Evaluation of in vitro predictive assays for acute myelocytic leukemia.

Authors:  H D Preisler
Journal:  Blut       Date:  1980-11

3.  Adjuvant immune stimulation with Corynebacterium parvum during maintenance chemotherapy of acute myeloid leukemia. A prospective randomized study.

Authors:  E la Cour Petersen; P Hokland; J Ellegaard
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

4.  Remission-induction regimens in acute nonlymphocytic leukemia.

Authors:  D C Brennan; J P Lewis
Journal:  West J Med       Date:  1980-10

5.  Routine bone marrow examination in the management of acute lymphoblastic leukaemia of childhood.

Authors:  C Haworth; A D Heppleston; P H Morris Jones; R H Campbell; D I Evans; M K Palmer
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

6.  Serum thymidine kinase in acute leukaemia.

Authors:  H Hagberg; S Gronowitz; A Killander; C Källander; B Simonsson; C Sundström; G Oberg
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

7.  A score at diagnosis for predicting length of remission in childhood acute lymphoblastic leukaemia.

Authors:  M K Palmer; I M Hann; P M Jones; D I Evans
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640

8.  Stem cell origins of leukaemia and curability.

Authors:  M F Greaves
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

9.  Treatment of acute myeloid leukaemia with a triple cytotoxic regime: DAT.

Authors:  J K Rees; R M Sandler; J Challener; F G Hayhoe
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.